4//SEC Filing
DRMANAC RADOJE T 4
Accession 0001181431-11-052826
CIK 0001361103other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 2:24 PM ET
Size
6.1 KB
Accession
0001181431-11-052826
Insider Transaction Report
Form 4
DRMANAC RADOJE T
Chief Scientific Officer
Transactions
- Disposition to Issuer
Common Stock, $0.001 par value
2011-10-13$4.97/sh−10,000$49,748→ 118,666 total(indirect: By Trust)
Holdings
- 13,333(indirect: By Corporation)
Common Stock, $0.001 par value
Footnotes (3)
- [F1]The shares sold were pursuant to a Rule 10b5-1 plan dated March 17, 2011. The transaction was executed in multiple trades in prices ranging from $4.86 to $5.03 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F2]These shares are held by the Drmanac Family Trust dated June 21, 2000, Radoje Drmanac, Trustee.
- [F3]These shares are held by Callida Genomics, Inc., a corporation wholly owned by the Reporting Person and his wife.
Documents
Issuer
COMPLETE GENOMICS INC
CIK 0001361103
Entity typeother
Related Parties
1- filerCIK 0001055672
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 2:24 PM ET
- Size
- 6.1 KB